Obesity

There are 14,199 papers on obesity in aging research: 1,831 trials and 6,550 observational studies in people, 1,378 in animals, 41 in cells, 3,940 reviews. The newest story, Nov 21, 2026: “Antibody improved bone strength after gastric bypass in mice”.

Disease

14,199 papers study it6,926 more mention it2,890 findings

MeSH

1,610 new papers in 30 daysSee all 21,127 papers on obesity

“Postprandial multi-omic analytes showed stronger associations with obesity indicators than fasting measures.”
Multi-omics analysis of dynamic profiles in response to various nutrient loads provides novel insights into obesityClinical nutrition (Edinburgh, Scotland)2026doi:10.1016/j.clnu.2026.106607
  • Human trial1,831
  • Humans6,550
  • Animals1,344
  • Model organisms34
  • Cells41
  • In silico233

Interventions

34

GLP-1 receptor agonists

downin humans3

3 studies
  1. GLP-1 receptor agonists decrease obesity in humans.

    Review

  2. GLP-1 receptor agonists decrease obesity in severe mental illness.

    Reviewin severe mental illness

  3. GLP-1 receptor agonists decrease obesity in humans.

    Review

More on GLP-1 receptor agonists

Caloric restriction

downin mice1downin reviews1

2 studies
  1. Caloric restriction decreases obesity in mice (HFD-induced obese mice).

    AnimalsHFD-induced obese mice12 weeks

  2. Caloric restriction decreases obesity (obesity).

    Reviewobesity

More on Caloric restriction

Bariatric surgery

downin humans2

2 studies
  1. Bariatric surgery decreases obesity in humans (severe or treatment-resistant obesity) (highly effective, durable outcomes).

    Reviewsevere or treatment-resistant obesity

  2. Bariatric surgery decreases obesity in obesity and associated medical problems.

    Reviewin obesity and associated medical problems

More on Bariatric surgery

Low-fat diet

downin humans1−72% moved to ob_low

1 study
  1. Low-fat diet decreases obesity in humans among men (72% moved to OB_Low).

    Human trialamong men4 monthsn = 16

  2. Low-fat diet decreases obesity in men.

    Human trialin menmales

More on Low-fat diet

High-protein diet

downin humans1−66% moved to ob_low

1 study
  1. High-protein diet decreases obesity in humans among women (66% moved to OB_Low).

    Human trialamong women4 monthsn = 26

  2. High-protein diet decreases obesity in women.

    Human trialin womenfemales

More on High-protein diet

Asparagus racemosus

downin humans1

1 study
  1. Asparagus racemosus decreases obesity in humans (42.99% to 29.91%).

    Human trial90 daysfemalesn = 214

  2. Asparagus racemosus decreases obesity in humans (postmenopausal women) (from 42.99% to 29.91%).

    Human trialpostmenopausal womenhydroalcoholic extract of root standardized to 5% shatavarins250 mg/day90 daysfemalesn = 214

More on Asparagus racemosus

Metabolic bariatric surgery

downin humans1

1 study
  1. Metabolic bariatric surgery decreases obesity in humans.

    Reviewlong-term

More on Metabolic bariatric surgery

FGF21 + SIRT1 gene therapy

downin mice1

1 study
  1. FGF21 + SIRT1 gene therapy decreases obesity in mice (obese mice) (∼33% reduction).

    Animalsobese micesingle dose70 weeks

    Combination gene therapy extended lifespan in aged obese mice

    Molecular therapy. Nucleic acids

More on FGF21 + SIRT1 gene therapy

Postbiotics

downin reviews1

1 study
  1. Postbiotics protect against obesity.

    Review

More on Postbiotics

Antiretroviral therapy switch

no changein humans1

1 study
  1. Antiretroviral therapy switch showed no clear effect on obesity in people with HIV with established obesity.

    Reviewin people with HIV with established obesity

More on Antiretroviral therapy switch

Roux-en-y gastric bypass

downin humans1

1 study
  1. Roux-en-y gastric bypass decreases obesity in humans (66.7% diabetic, 60.7% hypertensive, 50% dyslipidemic, 66.7% OSA).

    Human trial5 yearsn = 81

More on Roux-en-y gastric bypass

All 34

Effects

86

Inflammation

upin humans3upin silico1

4 studies
  1. Obesity increases inflammation in humans.

    Review

  2. Obesity increases inflammation in humans.

    Review

  3. Obesity induces inflammation in silico (digital twin simulation).

    In silicodigital twin simulationfemalesn = 1,000

  4. Obesity induces inflammation in humans.

    Review

More on Inflammation

Frailty

upin humans2mediatesin humans1

3 studies
  1. Obesity is linked with frailty in humans (socioeconomic disadvantage-frailty association) (13-55%).

    Humanssocioeconomic disadvantage-frailty associationup to 16 yearsn = 4,731

  2. Obesity increases frailty in humans (coexisting sarcopenia).

    Reviewcoexisting sarcopenia

  3. Obesity increases frailty in humans (kidney failure).

    Reviewkidney failure

Mortality

upin humans1no changein humans1

2 studies
  1. Obesity was not clearly linked with mortality in humans (Patients with NSTEMI; adjusted analysis in both cohorts).

    HumansPatients with NSTEMI; adjusted analysis in both cohorts10 years

  2. Obesity increases mortality in humans (coexisting sarcopenia).

    Reviewcoexisting sarcopenia

Handgrip strength

no changein humans2

2 studies
  1. Obesity was not clearly linked with handgrip strength in humans.

    Humansfemalesn = 499

  2. Obesity was not clearly linked with handgrip strength in adults with sarcopenia.

    Humansin adults with sarcopenia

Cognitive function

downin humans2

2 studies
  1. Obesity impairs cognitive function in humans.

    Review

  2. Obesity impairs cognitive function in humans.

    Review

Systolic blood pressure

upin humans2

2 studies
  1. Obesity is linked with higher systolic blood pressure in adults with sarcopenia (p < 0.01).

    Humansin adults with sarcopenia

  2. Obesity is linked with higher systolic blood pressure in humans with aging.

    Humanswith aging

More on Systolic blood pressure

Cellular senescence

upin humans1upin reviews1

2 studies
  1. Obesity induces cellular senescence.

    Reviewadipose tissue

  2. Obesity induces cellular senescence in humans (donor obesity).

    Reviewdonor obesity

More on Cellular senescence

HOMA-beta

no changein humans1upin humans1

1 study
  1. Obesity was not clearly linked with HOMA-beta in humans (elderly individuals without a history of diabetes).

    Humanselderly individuals without a history of diabetesfemalesn = 220

  2. Obesity is linked with higher HOMA-beta in humans (elderly individuals without a history of diabetes).

    Humanselderly individuals without a history of diabetesmalesn = 258

More on HOMA-beta

Precision of body composition assessment

downin humans1

1 study
  1. Obesity decreases precision of body composition assessment in humans (dual-energy X-ray absorptiometry).

    Reviewdual-energy X-ray absorptiometry

Insulin resistance

upin humans1

1 study
  1. Obesity increases insulin resistance in humans (polycystic ovary syndrome).

    Reviewpolycystic ovary syndrome

More on Insulin resistance

All 86

Upstream

11

TRENDS

downin humans1upin humans1

1 study
  1. trends are linked with lower obesity in humans (APCs: -1.9% and -1.5%).

    Humans2005-2023females

  2. trends are linked with higher obesity in humans (APCs: 1.7% and 2.4%).

    Humans2005-2023males

Taurinivorans overgrowth

upin mice1

1 study
  1. Taurinivorans overgrowth increases obesity in mice (Taurinivorans overgrowth and host taurine depletion).

    AnimalsTaurinivorans overgrowth and host taurine depletion

    Disrupted immune signaling promotes obesity as mice age

    Immunity

FLT1

downin mice1

1 study
  1. FLT1 protects against obesity in mice (shown by conditional Flt1 deletion in T cells).

    Animalsshown by conditional Flt1 deletion in T cellsT cell

    Disrupted immune signaling promotes obesity as mice age

    Immunity

More on FLT1

Fresh fruit and vegetable shops

no changein humans1

1 study
  1. fresh fruit and vegetable shops were not clearly linked with obesity in humans (multivariable adjusted analysis in urban slums).

    Humansmultivariable adjusted analysis in urban slumsn = 6,134

GRPEL2

upin mice1

1 study
  1. GRPEL2 increases obesity in mice (shown by knockout; age- and diet-induced weight gain).

    Animalsshown by knockout; age- and diet-induced weight gain

    Mice lacking a mitochondrial helper protein resist weight gain

    Mitochondrion

More on GRPEL2

Age 35–39 years

upin humans1

1 study
  1. age 35–39 years are linked with higher obesity in humans (15.9% vs 3.9%).

    Humans

FOXO3

downin mice1

1 study
  1. FOXO3 protects against obesity in mice (shown by hepatocyte-specific knockout) (moderate obesity).

    Animalsshown by hepatocyte-specific knockoutmales

More on FOXO3

C2ORF74

upin mice1

1 study
  1. C2ORF74 increases obesity in mice (high-fat diet).

    Animalshigh-fat dietmales

More on C2ORF74

SLC25A51

downin mice1

1 study
  1. SLC25A51 protects against obesity in mice (Slc25a51 overexpression during aging).

    AnimalsSlc25a51 overexpression during agingadipocyte

More on SLC25A51

Insomnia

no changein humans1

1 study
  1. Insomnia was not clearly linked with obesity in humans.

    Humans6.2 ± 2.0 years

More on Insomnia

All 11

Associations

442

Hypertension

upin humans34mixedin humans2downin humans1upin reviews1OR 2.568–9.68

37 studies
  1. Obesity is associated with hypertension in humans (Multivariable analysis in older adults in China) (OR = 2.568, 95% CI 1.977–3.336).

    HumansMultivariable analysis in older adults in Chinan = 7,733

    High blood pressure often uncontrolled in older Chinese adults

    Scientific reports
  2. Hypertension is associated with obesity in humans (Paraguayan adults; adjusted multivariable model) (aOR 2.5, 95% CI 2.1–3.0).

    HumansParaguayan adults; adjusted multivariable modeln = 5,098

  3. Obesity is associated with hypertension in humans (large waist circumference; adults in India) (AOR 1.77, 95% CI 1.45–2.17).

    Humanslarge waist circumference; adults in Indian = 59,658

  4. Hypertension is associated with obesity in humans (Consistently observed across CHARLS, CHNS and CFPS).

    HumansConsistently observed across CHARLS, CHNS and CFPS

    Obesity linked to clusters of diabetes and heart disease

    Diabetes, obesity & metabolism
  5. Obesity is associated with hypertension in humans (Premarital examination participants in Guangxi, China; multivariate regression) (OR 3.90, 95% CI 2.29–6.64).

    HumansPremarital examination participants in Guangxi, China; multivariate regressionn = 11,283

  6. Obesity is associated with hypertension in humans (Community-dwelling adults in Amasya, Türkiye; adjusted for age and sex) (aOR 2.50, 95% CI 2.31–2.70).

    HumansCommunity-dwelling adults in Amasya, Türkiye; adjusted for age and sexBoth; 50.6% womensn = 22,667

  7. Obesity is linked with a higher risk of hypertension in humans (obesity trajectory vs average trajectory) (HR = 4.31 (95% CI: 3.45-5.37)).

    Humansobesity trajectory vs average trajectorymales

  8. Obesity is linked with a higher risk of hypertension in 2022 (AOR 5.3, 95% CI 3.2-8.7).

    Humansin 2022

  9. Obesity is associated with hypertension in humans (PR 2.01; 95% CI 1.70–2.38).

    Humansn = 2,255

  10. Obesity is linked with a higher risk of hypertension in humans (AOR=2.60, 95% CI: 1.50–4.50).

    Humans

All 38

More on Hypertension

Cardiovascular disease

upin humans16upin reviews1OR 1.92

17 studies
  1. Obesity is associated with cardiovascular disease in humans (Community-dwelling adults in Amasya, Türkiye; adjusted for age and sex) (aOR 2.29, 95% CI 2.05–2.56).

    HumansCommunity-dwelling adults in Amasya, Türkiye; adjusted for age and sexBoth; 50.6% womensn = 22,667

  2. Obesity is linked with a higher risk of cardiovascular disease in younger adults.

    Humansin younger adultsmedian follow-up of 4.5 years

    Cardiovascular risk from metabolic burden weakens with age

    The Lancet regional health. Western Pacific
  3. Obesity is linked with a higher risk of cardiovascular disease in premenopausal women without MASLD (aHR 1.10, 95% CI 1.04-1.17).

    Humansin premenopausal women without MASLDfemales

  4. Obesity is linked with a higher risk of cardiovascular disease in humans (BMI-based persistent obesity) (aHR 1.31, 95% CI 1.20-1.44).

    HumansBMI-based persistent obesity

  5. Obesity is associated with cardiovascular disease in middle-aged (31-60 years) PWH at ART initiation (composite outcome of CVD/cancer/death) (aHR 1.49 [95% CI 1.11, 2.00]).

    Humansin middle-aged (31-60 years) PWH at ART initiation (composite outcome of CVD/cancer/death)

  6. Obesity is linked with a higher risk of cardiovascular disease in humans (OR 1.92; 95% CI 1.38-2.65).

    Humans

  7. Obesity is associated with cardiovascular disease in humans (aOR = 2.6 [95% CI: 1.5, 4.5]).

    Humansfemales

  8. Obesity is associated with cardiovascular disease in humans.

    Humans

  9. Obesity is linked with a higher risk of cardiovascular disease in humans (BMI25 ≥28.0 kg/m2 compared with BMI25 18.5-20.0 kg/m2) (HR 1.85 (95% CI: 1.71-2.00)).

    HumansBMI25 ≥28.0 kg/m2 compared with BMI25 18.5-20.0 kg/m2

  10. Obesity raises the risk of cardiovascular disease.

    Review

All 17

More on Cardiovascular disease

Mortality

upin humans11downin humans3HR 0.601–10.44

14 studies
  1. Obesity is associated with mortality in humans (EASO- and BMI-defined obesity).

    HumansEASO- and BMI-defined obesityMedian follow-up of 13.02 yearsn = 408,453

    Obesity and unhealthy sleep linked to highest death risk

    Research SquarePreprint
  2. Obesity is associated with mortality in humans (HeartMate 3 recipients; adjusted for baseline case-mix) (HR 1.35, 95% CI 1.10–1.67).

    HumansHeartMate 3 recipients; adjusted for baseline case-mix24 monthsn = 2,200

  3. Obesity is associated with mortality in humans (Atrial fibrillation; BMI ≥30 versus BMI 19–24.9) (HR 0.601, 95% CI 0.595–0.607).

    HumansAtrial fibrillation; BMI ≥30 versus BMI 19–24.9

    Obesity linked to lower stroke risk in heart rhythm study

    AHA Scientific Sessions 2026 abstract
  4. Obesity is associated with mortality in humans (UK Biobank; obesity classified by both EASO and Lancet frameworks).

    HumansUK Biobank; obesity classified by both EASO and Lancet frameworks

    Two obesity definitions identified different disease risk groups

    AHA Scientific Sessions 2026 abstract
  5. Obesity is associated with mortality in humans (HR 0.713 (95% CI 0.635–0.801)).

    HumansHospitalized patients with a COPD-coded diagnosis; obesity compared with normal weight, Model 3360 daysn = 9,228

  6. Obesity is associated with mortality in humans (VA ECMO patients) (HR=10.44).

    HumansVA ECMO patients90 daysn = 180

  7. Obesity is associated with mortality in humans (Heart failure).

    HumansHeart failure

  8. Obesity is associated with mortality in humans (Participants with 3–4 metabolic syndrome components) (HR 2.07, 95% CI 1.18–3.64).

    HumansParticipants with 3–4 metabolic syndrome componentsMedian follow-up of 17.3 years

  9. Obesity is linked with a higher risk of mortality in humans (geriatric patients undergoing surgery for spinal metastases).

    Humansgeriatric patients undergoing surgery for spinal metastases1-yearn = 116

  10. Obesity is linked with a higher risk of mortality in humans (HR 1.16, 95% CI 1.12-1.20).

    Humans

All 14

Type 2 diabetes

upin humans11upin reviews1HR 2.52–6

12 studies
  1. Obesity is associated with type 2 diabetes in humans (Class III obesity) (4.32-fold hazard).

    HumansClass III obesity

  2. Obesity predicts type 2 diabetes in humans (HR 2.52, 95% CI 2.06–3.09; obesity preceded diabetes in 83.87% of sequential onsets).

    HumansFive yearsn = 8,383

  3. Obesity is associated with type 2 diabetes in humans (aOR = 1.65; 95% CI: 1.35-2.01).

    Humansn = 37,157

  4. Obesity is associated with type 2 diabetes in humans (Multivariate analysis) (OR=1.588).

    HumansMultivariate analysisn = 2,097

  5. Obesity is linked with a higher risk of type 2 diabetes in humans (general adiposity strategy) (pooled HR 6.00, 95% CI 3.71-9.70).

    Humansgeneral adiposity strategyapproximately 8 years

  6. Obesity is linked with a higher risk of type 2 diabetes in humans (unadjusted, compared with normal weight) (HR 5.06, 95% CI 3.86-6.62).

    Humansunadjusted, compared with normal weight

  7. Obesity is linked with a higher risk of type 2 diabetes in humans (nonobese BMI with clinical obesity under new Lancet Commission criteria) (HR 3.18 (95% CI 3.04, 3.33)).

    Humansnonobese BMI with clinical obesity under new Lancet Commission criterian = 173,698

  8. Obesity is associated with type 2 diabetes in humans.

    Humans

  9. Obesity is linked with a higher risk of type 2 diabetes in humans (obese vs. normal-weight) (37.1% vs. 14.9%).

    Humansobese vs. normal-weightn = 2,877

  10. Type 2 diabetes is associated with obesity in humans (longitudinal study).

    Humanslongitudinal studyn = 1,252

All 12

More on Type 2 diabetes

Diabetes mellitus

upin humans11OR 2.33–3.25

11 studies
  1. Obesity is associated with diabetes mellitus in humans (individual-level obesity) (OR 2.33, 95% CI 2.28–2.38).

    Humansindividual-level obesityn = 406,782

  2. Obesity is associated with diabetes mellitus in humans (CHARLS) (OR 2.59, 95% CI 2.18–3.11).

    HumansCHARLS2011–2015n = 12,491

    Obesity linked to clusters of diabetes and heart disease

    Diabetes, obesity & metabolism
  3. Obesity is associated with diabetes mellitus in humans (Community-dwelling adults in Amasya, Türkiye; adjusted for age and sex) (aOR 2.88, 95% CI 2.65–3.14).

    HumansCommunity-dwelling adults in Amasya, Türkiye; adjusted for age and sexBoth; 50.6% womensn = 22,667

  4. Obesity is associated with diabetes mellitus in humans.

    Humans

  5. Obesity is linked with a higher risk of diabetes mellitus in humans (OR=3.2).

    Humansn = 150

  6. Obesity is linked with a higher risk of diabetes mellitus in humans (AOR 3.5; 95% CI: 1.8–6.8).

    Humansn = 400

  7. Obesity is associated with diabetes mellitus in humans (TB patients) (33.3% vs. 4.2%, P = 0.007).

    HumansTB patientsn = 50

  8. Diabetes mellitus is associated with obesity in humans (adults with diabetes mellitus with a duration of ≥5 years) (AOR 1.1, 95% CI 1.0-1.1).

    Humansadults with diabetes mellitus with a duration of ≥5 yearsn = 189

  9. Obesity is associated with diabetes mellitus in humans (survey-weighted logistic regression model) (OR: 2.70; 95% CI: 1.96-3.72).

    Humanssurvey-weighted logistic regression model

  10. Obesity is linked with a higher risk of diabetes mellitus in humans (compared to normal participants) (OR = 3.25).

    Humanscompared to normal participantsn = 3,048

All 11

More on Diabetes mellitus

Cancer

upin humans8upin reviews1HR 1.4–1.43

9 studies
  1. Obesity is linked with a higher risk of cancer in humans (HR 1.43, 95% CI 1.14-1.80).

    Humansn = 11,951

  2. Obesity is linked with a higher risk of cancer in humans (BMI25 ≥28.0 kg/m2 compared with BMI25 18.5-20.0 kg/m2) (HR 1.40 (95% CI: 1.26-1.56)).

    HumansBMI25 ≥28.0 kg/m2 compared with BMI25 18.5-20.0 kg/m2

  3. Obesity is linked with a higher risk of cancer in humans (BMI >= 30 kg/m2 in chronic kidney disease) (aHR 1.080, 95% CI 1.056-1.105).

    HumansBMI >= 30 kg/m2 in chronic kidney diseasemedian 7.7 years

  4. Obesity is associated with cancer in humans.

    Review

  5. Obesity raises the risk of cancer (at least 13 types of cancer).

    Review

  6. Obesity raises the risk of cancer in humans (childhood obesity).

    Reviewchildhood obesity

  7. Obesity raises the risk of cancer in humans.

    Review

  8. Obesity raises the risk of cancer in humans (at least 13 cancer types).

    Review

  9. Obesity raises the risk of cancer in humans.

    Review

More on Cancer

Breast cancer

upin humans6upin silico1upin reviews1OR 2.61–2.74

8 studies
  1. Obesity is linked with a higher risk of breast cancer in humans.

    Humans

  2. Obesity is associated with breast cancer in humans.

    Reviewfemales

  3. Obesity raises the risk of breast cancer in humans (OR = 2.61; 95% CI: 1.86-3.66).

    Reviewfemales

  4. Obesity raises the risk of breast cancer (particularly in postmenopausal women).

    Reviewparticularly in postmenopausal women

  5. Obesity raises the risk of breast cancer in humans (particularly after menopause).

    Reviewparticularly after menopausefemales

  6. Obesity raises the risk of breast cancer in humans (WHR > 0.85) (OR=2.74; 95% CI: 1.85-4.07).

    ReviewWHR > 0.85females

  7. Obesity is associated with breast cancer in humans.

    Reviewfemales

  8. Obesity is associated with breast cancer in silico (PAF 2.8%).

    In silicofemales

More on Breast cancer

Multimorbidity

upin humans7OR 2.8

7 studies
  1. Obesity is associated with multimorbidity in humans (White breast cancer survivors; compared with those without obesity).

    HumansWhite breast cancer survivors; compared with those without obesity

  2. Obesity is associated with multimorbidity in humans (Adjusted OR 2.80, 95% CI 2.50-3.13).

    Humansn = 20,759

  3. Multimorbidity is associated with obesity in humans.

    Humansn = 1,985

  4. Obesity is associated with multimorbidity in humans.

    Humans

  5. Obesity is linked with a higher risk of multimorbidity in humans (HR 1.52-2.17).

    Humans23 yearsfemales

  6. Obesity is associated with multimorbidity in humans (obesity).

    Humansobesity

  7. Obesity is associated with multimorbidity in humans.

    Review

More on Multimorbidity

Chronic kidney disease

upin humans6OR 1.46

6 studies
  1. Obesity is associated with chronic kidney disease in humans (Ghanaian clinic attendees) (aORs 7–8 for Obese I/II).

    HumansGhanaian clinic attendeesn = 203

  2. Chronic kidney disease is associated with obesity in humans (Adults with versus without chronic kidney disease; obesity defined as BMI ≥30 kg/m2) (OR 1.46, 95% CI 1.41-1.51; prevalence 42.1% versus 33.3%).

    HumansAdults with versus without chronic kidney disease; obesity defined as BMI ≥30 kg/m2n = 327,671

  3. Obesity is linked with a higher risk of chronic kidney disease in hypertensive patients (AHR 2.56, 95% CI 1.63-4.01).

    Humansin hypertensive patients

  4. Obesity raises the risk of chronic kidney disease in humans.

    Review

  5. Obesity raises the risk of chronic kidney disease in humans.

    Review

  6. Obesity raises the risk of chronic kidney disease in humans (chronic kidney disease).

    Reviewchronic kidney disease

More on Chronic kidney disease

Dyslipidemia

upin humans6OR 1.22–2.81

6 studies
  1. Obesity is associated with dyslipidemia in humans (AOR 4.24 (95% CI: 2.34-7.66)).

    Humans

  2. Obesity is linked with a higher risk of dyslipidemia in humans (obesity compared with normal weight) (aOR 1.86 (95% CI 1.60–2.16)).

    Humansobesity compared with normal weight

  3. Obesity is associated with dyslipidemia in humans (compared with patients of normal weight) (OR = 2.26 (95% CI: 1.59-3.21)).

    Humanscompared with patients of normal weightn = 1,145

  4. Obesity is linked with a higher risk of dyslipidemia in humans after adjusting for confounding factors (OR 2.81 (95% CI 1.78-4.43)).

    Humansafter adjusting for confounding factors5 yearsfemales

  5. Obesity is linked with a higher risk of dyslipidemia in humans (OR = 1.22, 95% CI: 1.05-1.42).

    Humansn = 11,561

  6. Obesity is linked with a higher risk of dyslipidemia in humans (rural North-Indian population) (P < 0.005).

    Humansrural North-Indian populationn = 456

More on Dyslipidemia

Rate-pressure product

upin humans1

1 study
  1. Obesity is associated with rate-pressure product in humans.

    Human trialWomen with obesity compared with middle-aged women without obesity and young women during whole-body heat stressEnd of heatingfemalesn = 10

More on Rate-pressure product

Postprandial multi-omic analytes

upin humans1

1 study
  1. Postprandial multi-omic analytes are associated with obesity in humans.

    Human trialn = 147

More on Postprandial multi-omic analytes

All 442

Trial sponsors

Funding

473 grants since 2016

National Institute of Diabetes and Digestive and Kidney Diseases$129MNational Heart, Lung, and Blood Institute$42.6MNational Institute on Aging$22M

Latest

Metabolism

Antibody improved bone strength after gastric bypass in mice

Eight weeks of an antibody improved bone and metabolic measures in obese female mice with ovaries removed, but also made outer bone more porous.Eight weeks of an antibody improved bone and metabolic measures in obese female mice with ovaries removed, but also made outer bone more porous.

Mouse studyBones and joints

See all 21,127 papers on obesity